Clinical Trials Logo

Clinical Trial Summary

Following surgical removal of diseased bowel, patients often require a temporary redirection of bowel contents to a stoma, to allow healing prior to re-joining of the remaining bowel at a later date. Some patients may experience complications, either during or after reversal surgery, and this may be due to changes in the 'friendly' bacteria that live in our bowels. Previous research shows that the distal section of bowel that is non-functioning undergoes tissue-wasting and the 'friendly' bacteria that help our digestion die. Data shows that patients that have a reduction in their microflora are more likely to experience side effects. This study investigates a method of replenishing the microflora prior to surgery.


Clinical Trial Description

Surgical formation of a loop ileostomy to divert the faecal stream and allow tissue healing, with the aim of re-joining the bowel around 1 year later, is carried out in around 9000 patient per year in the United Kingdom (UK). One in 4 patients experience severe side effects, such as inflammation or lack of function following reversal, and 5% of patients cannot undergo reversal, leaving them with a permanent stoma. Previous data shows that patients with less bacteria in the distal bowel may be more likely to develop post-operative complications. This study investigates a method of replenishing the microflora prior to surgery. The data also shows that patients with less bacteria in the distal bowel may be more likely to develop post-operative complications. This study will pilot a clinical trial to assess whether enteral feeding in these 'high risk' patients alters the microflora, prior to applying to complete a randomised, controlled trial to assess the effectiveness of enteral feeding in standard-care patients. The enteral feeding is carried out through a feeding tube into the defunctioned part of the stoma. Initially patients receive saline and build up to approximately 100ml of 'Ensure™', a nutrition shake containing 9 amino acids and various vitamins and minerals, over a period of approximately 4 weeks. A source of fibre will be added to the shake, a Chicory root extract made by BENEO™, for the final week to 10 days of stoma feeding. There is evidence to support that oral consumption, in both adult and paediatric patients, of the chicory root extract supports positive microflora growth. We propose to supplement Ensure™ with up to 10g of chicory root extract for the final 7-10 days of stoma feeding and assess the changes on both the microbiota and on the histological and biomolecular properties of the intestinal tissues. This research aims to investigate ways to increase the numbers of friendly bacteria to improve the health of the distal, non-functioning, bowel by adding fibre to the nutritional supplement fed to the distal bowel for around two weeks prior to surgery. The aim is that this will reduce the risk of complications and possibly reduce the recovery time from bowel surgery. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06288464
Study type Interventional
Source Lancashire Teaching Hospitals NHS Foundation Trust
Contact Kina Bennett
Phone (+44) 01772 522031
Email kina.bennett@lthtr.nhs.uk
Status Recruiting
Phase N/A
Start date January 9, 2023
Completion date December 1, 2025

See also
  Status Clinical Trial Phase
Recruiting NCT04205058 - Coffee After Pancreatic Surgery N/A
Recruiting NCT05380856 - Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction N/A
Completed NCT00135577 - Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects Phase 2
Completed NCT03028636 - LIBERATE - PRO: Eclipse™ System Registry
Active, not recruiting NCT05880446 - PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ) N/A
Active, not recruiting NCT06311110 - Impaired Toilet Training, LUTS and Bowel Dysfunction in Children With DCD
Not yet recruiting NCT04507945 - Stablishment of Prevention and Treatment System for Intestinal Dysfunction Phase 1/Phase 2
Completed NCT00101998 - Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication Phase 2
Recruiting NCT05716230 - Bowel Function and Associated Risk Factors for Bowel Dysfunciton in Patients With Anorectal Malformation
Completed NCT05644912 - Exploratory Investigation on a Novel Catheter N/A
Recruiting NCT04319991 - The Clinical Evaluation of Probiotics Product in Patients With Various Functional Bowel Disorders and Helicobacter Pylori Infection N/A
Completed NCT03885999 - Studies in Patients With Low Anterior Resection Syndrome (LARS) N/A
Active, not recruiting NCT04546672 - Sugammadex To IMprove Bowel Function Phase 4
Not yet recruiting NCT06252714 - Impact of Defecation Posture on Ease of Bowel Movements in Patients With a Rectocele N/A
Recruiting NCT04914975 - The Effect of NMES on Bowel Management in People With Chronic SCI N/A
Active, not recruiting NCT04490642 - Linguistic Validation of the Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ) for 5-12 Years Old in Korean
Completed NCT04299867 - Perioperative Tissue Penetration of Antimicrobials in Infants
Completed NCT05351138 - Comparison of Transcutaneous Electrical Nerve Stimulation and Manual Therapy in Children With Cerebral Palsy N/A
Completed NCT03841513 - Minimally Invasive Burch Colposuspension to Reduce Occult Stress Incontinence N/A
Not yet recruiting NCT03009747 - A Prospective Multi-Center Research on Bowel Dysfunction After Sphincter Preservative Surgery N/A